A novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion

  1. Lookup NU author(s)
  2. Dr Noel Edwards
  3. Dr Simon Ramsbottom
  4. Professor John Sayer
Author(s)Edwards N, Olinger E, Adam J, Kelly M, Schiano G, Ramsbottom SA, Sandford R, Devuyst O, Sayer JA
Publication type Article
JournalNephrology Dialysis Transplantation
ISSN (print)0931-0509
ISSN (electronic)1460-2385
Full text is available for this publication:
Heterozygous mutations in UMOD encoding the urinary protein uromodulin are the most common genetic cause of autosomal dominant tubulointerstitial kidney disease (ADTKD). We describe the exceptional case of a patient from a consanguineous family carrying a novel homozygous UMOD mutation (p.C120Y) affecting a conserved cysteine residue within the EGF-like domain III of uromodulin. Comparison of heterozygote and homozygote mutation carriers revealed a gene dosage effect with unprecedented low levels of uromodulin and aberrant uromodulin fragments in the urine of the homozygote proband. Despite an amplified biological effect of the homozygote mutation, the proband did not show a strikingly more severe clinical evolution nor was the near absence of urinary uromodulin associated with urinary tract infections or kidney stones
PublisherOxford University Press
Actions    Link to this publication

Altmetrics provided by Altmetric